Home / Netherlands / Pharming Group N.V.
Pharming Group N.V.
Short position disclosed on November 5, 2026.
Evolution of the disclosed total
January 23, 2014 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Citadel Advisors LLC | 1.29% | +0.65 pt | November 3, 2026 | |
| Citadel Securities (Europe) Limited | 0.79% | new | November 3, 2026 | |
| Two Sigma Investments, LP | 0.79% | new | November 5, 2026 | |
| Capstone Volatility Master (Cayman) Limited | 0.72% | -0.42 pt | September 11, 2026 | |
| D. E. Shaw & Co., L.P. | 0.68% | new | November 3, 2026 | |
| Whitebox Advisors LLC | 0.58% | -0.02 pt | June 3, 2026 |
In the United States PHGUF (OTC): 10,840,380 shares sold short on October 15, 2026. FINRA names no fund.
On the other side: the funds that hold Pharming Group N.V. Titelia
Get the moves on Pharming Group N.V. by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
Download 1,186 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the Netherlands
- Akzo Nobel N.V. 11.77% of the capital sold short
- Signify N.V. 9.15% of the capital sold short
- Fugro N.V. 4.77% of the capital sold short
- Avantium N.V. 3.41% of the capital sold short
- Imcd N.V. 3.36% of the capital sold short
- Basic-Fit N.V. 2.79% of the capital sold short
- DSM-Firmenich AG 2.67% of the capital sold short
- Alfen N.V. 2.40% of the capital sold short
- Sligro Food Group N.V. 2.29% of the capital sold short
- TomTom N.V. 2.17% of the capital sold short
- PostNL N.V. 2.11% of the capital sold short
- NSI N.V. 1.90% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Pharming Group N.V., source AFM, data as at November 5, 2026, https://www.quivad.com/action/pharming-group-n-v?page=4